Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC189 in Pediatric Influenza
CTR20242291Phase 3Completed
- Sponsor
- Jiaxing AnDiCon Biotech
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deunoxavir marboxil in Influenza A infection, influenza B, sponsored by Jiaxing AnDiCon Biotech. Started Jun 2024; status: completed.
02
Drugs
deunoxavir marboxil
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20242291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242291.